Content by Anglia Ruskin University

|2 min read

First T-Cell Therapy Improves Survival in ARDS Patients

Phase 1/2 trial data suggest that iNKT-cell therapy reduced systemic inflammation and pneumonia risk in patients on VV-ECMO
|2 min read

New COVID-19 Test Produces Reliable Results in 20 Minutes

The Cov2-ID qPCR test targets three viral genes instead of two, increasing reliability
Page 1 of 1